Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Walker Neal, Chairman & CEO. Officer active across 2 companies, notably Aclaris Therapeutics, Inc.. Cumulatively, 33 reports have been logged. Split: 0 buy · 5 sells. Total volume traded: €1.9m. Activity tracked since 9 February 2022. The latest transaction was filed on 1 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Walker Neal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Walker Neal is Président-Directeur Général and has filed 33 disclosures. Across the 33 sampled filings, all reported transactions are sales, for EUR 1923007, over the period from 2021-06-02 to 2026-02-05, with a dominant transaction nature of Levée d'options.